Skip to main content
Back
Watch Compare

BIOTRICITY INC.

Data quality: 100%
BTCY
OTC Manufacturing Measuring & Analyzing Instruments
$0.25
▼ $0.01 (-2.00%)
Mkt Cap: 7.01 M
Price
$0.25
Mkt Cap
7.01 M
Day Range
$0.25 — $0.27
52-Week Range
$0.20 — $0.75
Volume
40,100
Open $0.27
50D / 200D Avg
$0.26
4.03% below
50D / 200D Avg
$0.42
42.24% below

Quick Summary

Key Takeaways

Revenue grew 42.07% annually over 5 years — strong growth
Negative free cash flow of -1.10 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 27.75%
Interest coverage of 0.09× — tight debt servicing

Growth

Revenue Growth (5Y)
42.07%
Above sector avg (9.35%)
Revenue (1Y)14.32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net Margin-25.99%
Op. Margin0.91%

Safety

Debt / Equity
N/A
Current Ratio0.21
Interest Coverage0.09

Valuation

PE (TTM)
-1.74
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDA55.94
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -1.7 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -26.0 -150.2
Rev Growth 5Y % 42.1 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 14.32% Revenue Growth (3Y) 19.61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 42.07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 15.45 M Net Income (TTM) -4.02 M
ROE N/A ROA -66.88%
Gross Margin 81.09% Operating Margin 0.91%
Net Margin -25.99% Free Cash Flow (TTM) -1.10 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.21
Interest Coverage 0.09 Asset Turnover 2.57
Working Capital -18.82 M Tangible Book Value -34.24 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.74 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.45
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 55.94 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -15.68%
Market Cap 7.01 M Enterprise Value 7.90 M
Per Share
EPS (Diluted TTM) -0.16 Revenue / Share 0.54
FCF / Share -0.04 OCF / Share -0.04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 27.36%
SBC-Adj. FCF -1.17 M Growth Momentum -27.75

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.79 M 12.06 M 9.64 M 7.65 M 3.38 M
Net Income -8.42 M -14.09 M -18.66 M -29.13 M -15.49 M
EPS (Diluted) -0.56 -1.66 — — —
Gross Profit 10.56 M 8.36 M 5.44 M 4.57 M 1.51 M
Operating Income -2.45 M -8.83 M -15.41 M — —
EBITDA — — — — —
R&D Expenses 2.16 M 2.57 M 3.23 M 2.74 M 2.06 M
SG&A Expenses 10.86 M 14.61 M 17.62 M — —
D&A — — — — —
Interest Expense 364,000.0 3.02 M 1.84 M 379,500.0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.64 M 5.94 M 6.51 M 16.68 M 4.44 M
Total Liabilities 35.66 M 35.92 M 26.36 M 18.82 M 11.27 M
Shareholders' Equity -32.01 M -31.47 M -19.85 M -2.14 M -6.83 M
Total Debt — — — — —
Cash & Equivalents 365,145.0 786,060.0 570,460.0 12.07 M 2.20 M
Current Assets 4.64 M 4.47 M 4.72 M 15.32 M 4.32 M
Current Liabilities 20.64 M 22.70 M 11.16 M 4.87 M 10.49 M